Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis - Université de Tours Accéder directement au contenu
Article Dans Une Revue Arthritis & rheumatology Année : 2017

Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis

Résumé

Tumor necrosis factor inhibitors are effective in reducing inflammation in rheumatic diseases but increase the risk of infections. This study was undertaken to investigate the relationship between the trough serum concentration of infliximab (IFX) and the risk of a first infection episode.
Fichier non déposé

Dates et versions

hal-01980809 , version 1 (14-01-2019)

Identifiants

Citer

Theodora Bejan-Angoulvant, David Ternant, Fadela Daoued, Frédéric Medina, Louis Bernard, et al.. Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis. Arthritis & rheumatology, 2017, 69 (1), pp.108-113. ⟨10.1002/art.39841⟩. ⟨hal-01980809⟩

Collections

UNIV-TOURS CNRS
30 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More